Expression of nerve growth inhibiting factor Nogo-A mRNA and protein in the brain ischemic infarction rats

AIM: To investigate the changes of expression of Nogo-A at different time points in brain ischemic infarct rats. METHODS: The model of 80 cases of middle cerebral artery occlusion (MCAO) in rats was established. The expression of Nogo-A mRNA and protein were determined by Western blotting and hybridization, and the relationship between functional scoring and Nogo-A was also evaluated. RESULTS: In the brain of MCAO rats, Nogo-A mRNA expression was decreased on day 3 and increased significantly on day 7. The highest level was observed at the 21th d, keeping the same level at the 28th d. Nogo-A protein expression showed the same results. These results were correlated with the brain function scoring. CONCLUSION: Expression of Nogo-A does not increase in the early stage, but increases significantly in the late stage of MCAO, suggesting that Nogo-A expression may play an important role in the nerve regeneration of brain ischemic injury.     

Migration of enhanced green fluorescent protein labeled bone marrow after transplantation into rat cerebral infarct

AIM:To investigate the role of SDF-1α in migrating of bone marrow stromal cells to the injured areas.METHODS:Ischemic brain lesion model was created in rats by permanent middle cerebral artery occlusion (MCAO).48 SD rats were divided randomly into 2 groups.Group 1:phosphate buffered saline (PBS 1 mL) for control (n=25); Group 2:BMSCs (2×106) were injected intravenously at 24 h after MCAO (n=24).After propagated in BMSCs, Ad5/F35 GFP (green fluorescent protein) was infected to BMSCs.The expression of SDF-1α (stromal cell-derived factor-1α) mRNA in the penrumbral tissue was assayed by real-time quantitative PCR.The expression of CXCR4 on MSCs was detected by flow cytometry.Confocal microscopy was used to detect the GFP-labeled MSCs migration.RESULTS:Ad5/F35 GFP signals was observed in almost infected BMSCs.The expressions of SDF-1α mRNA in the thalamus and hippocampus of the ischemic brains were peaked at 3rd day after stroke, followed by a decrease at 14th day post-ischemia.The expression of SDF-1α mRNA in the cortex of the ischemic brains was peaked at 7th day post-ischemia, still at high level at 14th day post-ischemia.The median percentage of surface CXCR4 expression in BMSCs was 14%.GFP labeled BMSCs were detected in the origination of the middle cerebral artery (olfactory area) at 6 h, after 3 days in the prenumbra tissue such as thalamus, and in the cortex more labeled cells were found after 14 d post-ischemia.CONCLUSION:BMSCs can pass through the blood brain barrier of ischemic rats.Its mechanism might be associated with the expression of SDF-1α in the ischemic brain.     

Change of Th17/Treg in rat brain with acute ischemic stroke

AIM:To investigate the changes of T helper 17 (Th17) cells/regulatory T (Treg) cells in the brain of rats with acute ischemic stroke. METHODS:Acute middle cerebral artery occlusion (MCAO) model was established by thread embolization in SD rats, and sham operation was used as control. The infarct volume of the rats in each group was observed by TTC staining on day 3 after MCAO. The levels of interleukin-17A (IL-17A) and IL-10 in the brain tissues were measured by ELISA. RT-qPCR was used to detect the mRNA levels of IL-17, IL-10, Foxp3 and RORγt. The proportion of Th17 cells and Treg cells was measured by flow cytometry analysis. RESULTS:Compared with sham operation group, the protein level of IL-17A in MCAO group was increased (P<0.05), and the protein level of IL-10 was decreased (P<0.05). The mRNA expression of RORγt and IL-17 was increased (P<0.05), and the mRNA levels of Foxp3 and IL-10 were decreased (P<0.05). The proportion of Th17 cells was increased (P<0.05), while the proportion of Treg cells was decreased (P<0.05), and the Th17/Treg ratio was thus increased (P<0.05). CONCLUSION:The increase in Th17 cells and the decrease in Treg cells in the brain tissues of acute ischemic rats indicate that the immuno-inflammatory response is activated after cerebral infarction, and the balance of T helper 17/Treg is broken.     

Effects of ginsenoside RH2 on neovascularization of rats with middle cerebral artery occlusion

AIM: To investigate the effects of ginsenoside RH2 (GS-RH2) on neovascularization of rats with middle cerebral artery occlusion (MCAO) and its potential mechanisms. METHODS: SPF Sprague-Dawley rats were randomly divided into sham operation (sham) group, MCAO model (MCAO) group and GS-RH2 group, with 18 rats in each group. After surgery, the general condition and neurological function score of the rats were assessed. At the 1st day, 3rd day and 7th day after intervention, the microvessel density (MVD), the content of malondialdehyde (MDA) and the activity of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) were examined. The protein expression of kelch-like ECH-associated protein 1 (Keap1), nuclear factor E2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) was determined by Western blot. RESULTS: Compared with sham group, the rats in MCAO group showed significant neurobehavioral obstacles and ischemic brain infarction with higher neurological function score, while treatment with GS-RH2 significantly improved behavioral impairment and reduced the infarction volume with lower neurological function score. The MVD score in GS-RH2 group was increased as the animal survival time prolonged, while the MVD score in MCAO group was decreased. After intervention for 7 d, the MVD score in GS-RH2 group was significantly higher than that in MCAO group (P<0.05). Compared with sham group, the content of MDA was increased and the activities of SOD and GSH-Px were decreased in MCAO group at each time point. After intervention for 7 d, the MDA content was decreased and the SOD and GSH-Px activities were increased in GS-RH2 group compared with MCAO group. After intervention for 7 d, the protein expression of Nrf2 and HO-1 was increased, while the protein expression of Keap1 was decreased in GS-RH2 group compared with MCAO group(P<0.05). CONCLUSION: Ginsenoside RH2 promotes neovascularization of MCAO model rats. The mechanism may be related to the activation of Keap1/Nrf2 signaling pathway, promotion of the antioxidant enzyme activity and inhibition of oxidative stress.     

Protective effects of auricularia auricular polysaccharide on chronic cerebral ischemia injury in rats

AIM: To investigate the effects of auricularia auricular polysaccharide (AAP) on chronic cerebral ischemia injury in rats. METHODS: The chronic cerebral ischemia mode1 was made by permanent middle cerebral artery occlusion (MCAO) on the right side. AAP at different doses (50 mg/kg and 100 mg/kg) was intragastrically administered at the onset of ischemia and in the following days after operation, once a day for 4 weeks. After 4 weeks of MCAO, Morris water maze test was introduced to examine the learning and memory functions. Nissl staining was performed to detect the survival neurons in hippocampal slices. Level of malondialdehyde (MDA) and the activity of superoxide dismutase (SOD) in brain tissue were measured. RESULTS: Rats treated with AAP showed a shorter escaping latency in spacial navigation test because the AAP treated rats spent less time to find the platform in spatial probe test. More survival neurons in hippocampal slices were observed from AAP treated rats. Also, the MDA level in brain tissue was reduced and SOD activity in brain tissue was increased in the AAP treated rats with MCAO. CONCLUSION: AAP protects rats from chronic brain ischemic injury, in which its anti-oxidative effect might be involved.     

Study on changes of neurological function and neuron apoptosis after intravenous administration of bone marrow stromal stem cells for treating permanent focal cerebral ischemia in rats

AIM: To explore the survivorship and the mechanism of the intravenous administration of bone marrow stromal stem cells (BMSCs) for treating permanent focal cerebral ischemia in rats. METHODS: After purified, proliferated, and marked with BrdU, the BMSCs were injected intravenously into rats 1 d after focal cerebral ischemia.Modified neurological severity score (mNSS) was evaluated before and following 1, 7, 14 and 28 d after middle cerebral artery occlusion (MCAO). Rats were executed at 1, 7, 14 and 28 d after MCAO. Brain sections were stained with hematoxylin and eosin (HE) for determining the infarct volume. Slides were stained by the terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling (TUNEL) and immunostaining for cleaved caspase-3 method for apoptosis detection and mechanism exploration in situ.RESULTS: mNSS in BMSCs-transplanted group at 14th day and 28th day of MCAO was significantly lower than that in control group(P<0.05). TUNEL-positive cells in the hippocampus and thalamus area of BMSCs-transplanted rats were significantly fewer than those in control rats at 14th day and 28th day of MCAO(P<0.05). Double immunostaining showed that small grafted BMSCs and small endogenous neural cell apoptosis depended on the capase-3 in hippocampus.CONCLUSION: The intravenous administration of BMSCs promotes the recovery of neurological function of rats with focal cerebral ischemia. The therapeutic effect of BMSCs on rats with focal cerebral ischemia may be derived from the reduction of apoptosis and the mobility and migration of endogenous neural stem cells in the ischemic boundary zone.     

Brain damage of cerebral ischemia/reperfusion and expression of TGF-β1 mRNA in diabetic rats

AIM:To observe the difference of cerebral inj ury following ischemia/reperfusion and mR-NA expression of TGF-β₁ between diabetic and non-diabetic rats.METHODS:At first,Wistar rats weredivided i nto two groups,non-diabetes and diabetes,and then two groups followed by sham,middle cerebralartery occlusion(MCAO) 2h and reperfusion 24 h after MCAO 2 h respectively.TGF-β₁ mRNA expressionwas measured by semi-quantitative reverse transcri ption polymerase chain reaction(RT-PCR);Cerebraldamage was eval uated by histopathology.RESULTS:In the same condition of ischemia or ischemia/reperfu-sion,inj uried area enlarged in DMgroups;The expressionlevel of TGF-β₁ mRNA increased at the ti me of 2h after MCAOi n non-diabetic group and diabetic group,especialy significantly in non-diabetic group withMCAO 2 h,and decreased at the time of reperfusion 24 h after MCAO 2 h,but still higher than that in theshamgroup.CONCLUSION:Diabetes mellitus exacerbated brain lesion following ischemia/repefusion,in-creased TGF-β₁ mRNA expresion after MCAO may be an anti-injury reaction,and anti-injury abilityis de-creased under diabetic condition.     

cPKCγ-HSP60 signal pathway participates in hypoxic preconditioning in mice

AIM: To identify the proteins interacted with conventional protein kinase Cγ (cPKCγ) which are involved in hypoxic preconditioning (HPC), and to investigate the role of cPKCγ-interacted heat-shock protein 60 (HSP60) in the development of HPC and ischemia (I).METHODS: Healthy male BALB/c mice were randomly divided into normoxia(Norm) and HPC groups. Based on whether middle cerebral artery occlusion (MCAO) was performed, the mice were divided into Norm+sham group, Norm+I group, HPC+sham group and HPC+I group ( all n=6). Immunoprecipitation, two-dimensional electrophoresis and mass spectrometry were applied to identify the proteins interacted with cPKCγ. The changes of HSP60 expression in the brain of the mice after HPC and MCAO were analyzed by Western blotting.RESULTS: The interaction of cPKCγ and HSP60 was confirmed by co-immunoprecipitation result. Compared with Norm groups, the expression level of cPKCγ-interacted HSP60 obviously increased in particulate fraction of cerebral cortex in HPC mice. In the MCAO ischemic animals, the level of HSP60 expression was significantly higher in ischemic core and penumbra in Norm+I group and HPC+I group than that in Norm+sham group. HSP60 expression in ischemic core was lower in HPC+I group than that in Norm+I group.CONCLUSION: cPKCγ-HSP60 signal pathway might be involved in the development of cerebral hypoxic preconditioning in MCAO mice.     

Variation of CD8 after traumatic brain injury in serum of rats

AIM: To explore the character of CD8 after traumatic brain injury (TBI) in peripheral blood. METHODS: Improved Feeney's free-fall method was used to set up traumatic brain injury model. The levels of neuron-specific enolase (NSE) and CD8 in the serum of the rats were detected by ELISA. The correlation of both NSE and CD8 in the serum was analyzed by Pearson product-moment correlation. The FasL expression in the lymphocytes of peripheral blood was determined by Western blot. RESULTS: The elevated level of CD8 lagged behind the level of NSE in the serum after TBI. The serum level of NSE was significantly increased at the 1st day after TBI and reached a peak at the 3rd day, subsequently gradually decreased to a lower level; the serum level of CD8 was increased at the 3rd day after TBI, and reached a peak at the 7th day, then gradually decreased. The serum levels of NSE at 1st, 3rd and 7th days were positively correlated with the serum level of CD8 at 3rd, 7th and 14th days. However, the FasL expression in the CD8⁺ lymphocytes of peripheral blood showed no variation at different time points after TBI. CONCLUSION: NSE in the serum released from neural tissues after TBI stimulates immune response and induces the augmentation of CD8 in peripheral blood, which may be a cause of secondary injuries in the brain.     

Inhibitive action of atorvastatin on NADPH oxidase-derived superoxide anion in ischemic brain tissue after reperfusion in rats

AIM: Reactive oxygen species, specifically superoxide anion formed during the early phase of reperfusion, augment neuronal injury. The present study tested the hypothesis that atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide anion in transient focal ischemia. METHODS: Transient focal ischemia was created in halothane-anesthetized adult male Sprague-Dawley rats by middle cerebral artery occlusion (MCAO). Atorvastatin (Liptor) was administrated subcutaneously 3 times before MCAO. Infarct volume was measured by triphenyltetrazolium chloride staining. NADPH oxidase enzymatic activity and superoxide anion levels were quantified in both ischemic core and penumbral regions by lucigenin (5 μmol/L)-enhanced chemiluminescence. The expression of NADPH oxidase membrane subunit gp91phox, membrane-translocated subunit p47phox and small GTPase Rac-1 were determined by Western blotting analyses. RESULTS: NADPH oxidase activity and superoxide anion levels increased following reperfusion and peaked within 2 h of reperfusion in the penumbra, but not in the ischemic core in MCAO rats. Atorvastatin pretreatment prevented this increases, blunted the expression of membrane subunit gp91phox and prevented the translocation of cytoplasmic subunit p47phox to the membrane in the penumbra 2 h after reperfusion. CONCLUSION: These results indicate that atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide anion in ischemic brain tissue after reperfusion partly.     

Effect of renal transporter Glut9 on hyperuricemia in rats induced by fructose

AIM: To explore the effect of renal transporter glucose transporter 9 (Glu9) on hyperuricemia in the rats induced by fructose.METHODS: SD male rats (n=30) were randomly divided into normal group, model group and benzbromarone group, according to the weight. The rats in normal group was given water, while the rats in model group and benzbromarone group were given 10% fructose solution to establish hyperuricemia model. At the same time, the rats in normal group and model group were given a gavage of distilled water, while the rats in benzbromarone group were given benzbromarone at the dose of 20 mg/kg. The rats were sacrificed on the 40th day. The serum uric acid (SUA) and urinary uric acid (UUA) were detected to calculate the clearance rate of uric acid (CUA) in the kidney. The activity of hepatic xanthine oxidase (XOD) was also measured. The expression of renal Glut9 at mRNA and protein levels was determined by RT-qPCR and immunohistochemical staining. RESULTS: From the 20th day to the 40th day, the SUA in model group was significantly higher than that in normal group, but the UUA and CUA had no difference. On the 20th day, the SUA in benzbromarone group was markedly decreased as compared with model group, but UUA and CUA had no significant difference. On the 40th day, the hepatic XOD activity in model group was significantly elevated, and no difference of XOD between model group and the benzbromarone group was observed. Compared with normal group, the protein expression of Glut9 in the renal tissues of model group were markedly increased, and that in benzbromarone group was significantly lower than that in model group. However, no difference of the Glut9 mRNA expression was observed among groups. CONCLUSION: Fructose drinking induces hyperuricemia in rats, which is probably related to the up-regulation of renal Glut9 expression at protein level, and the increase in the reabsorption of uric acid in the kidneys.     

Tetramethylpyrazine combined with bone marrow mesenchymal stem cell transplantation inhibits neuronal apoptosis in rats with cerebral ischemia

ATM: To investigate the effects of tetramethylpyrazine (TMP) combined with bone marrow mesenchymal stem cells (BMSCs) on neuronal apoptosis, and Bcl-2 and Bax expression in rats with cerebral ischemia. METHODS: The BMSCs were isolated by the whole bone marrow adherent method and cultured, and those in the 3rd passage were used for tail-vein transplantation. The rats were subjected to right middle cerebral artery occlusion (MCAO) using suture method, and the rats except sham group were randomly divided into model group, BMSCs (1×10⁹ cells/L) group, TMP (40 mg/kg) group and combination (TMP+BMSCs) group with 12 rats in each group. Neurological function was evaluated by modified neurological severity scoring (mNSS) on 1 d, 7 d and 14 d after cerebral ischemia. Toluidine blue staining was performed to detect cerebral infarct volume, HE staining was used to observe brain histopathological change, neuronal apoptosis was observed by TUNEL staining, and the mRNA and protein expression of Bcl-2 and Bax was detected by real-time fluorescence quantitative PCR and Western blot at 14 d after cerebral ischemia. RESULTS: Compared with BMSCs group and TMP group, TMP combined with BMSCs significantly reduced the score of mNSS (P<0.01) and the infarct volume (P<0.01), alleviated the pathological damage in the peripheral area of cerebral ischemia, decreased the number of TUNEL positive cells (P<0.01), increased the expression of Bcl-2 and decreased the expression of Bax at mRNA and protein levels (P<0.01).CONCLUSION: Tetramethylpyrazine combined with transplantation of BMSCs improves the functional recovery, reduces the infarct volume, relieves the ischemic injury of the brain tissue, and attenuates neuronal apoptosis in the rats with cerebral ischemia. The mechanism may be related to regulating the expression of Bcl-2 and Bax.     

Effect of aminoguanidine on TNF-α,IL-1β and neuronal apoptosis after focal cerebral ischemic injury in rats

AIM: To evaluate the effect of aminoguanidine (AG) on inflammatory factors and neuronal apoptosis after focal cerebral ischemic injury in rats and the possible mechanism of protective effect of AG against cerebral ischemic injury.METHODS: Thirty male SD rats (weighing 250 g-280 g) were randomly divided into three groups: (1) sham operated group (SH group,n=10),(2) ischemic groups (IS group,n=10),(3) AG group (n=10).In AG group,AG at dose of 100 mg·kg-1 was given intraperitoneally twice a day for 3 consecutive days.In IS group,normal saline was given instead of AG.Focal cerebral ischemia was produced by middle cerebral artery occlusion (MCAO) for 12 h.A nylon thread with rounded tip was inserted into left internal carotid artery cranially until resistance was felt.The distance from bifurcation of common carotid artery to the tip of the thread was about 18-19 mm.Focal cerebral ischemia was confirmed by left Horners syndrome and right side hemiplegia.In SH group,the carotid artery was exposed but no thread was inserted.The expression of tumor necrosis factor-α(TNF-α) was determined by immunochemistry and the content of interleulin-1β(IL-1β) was measured by radioimmunoassay.The expressions of Bcl-2 and Bax protein were detected by flow cytometry.RESULTS: The expression of TNF-α and the content of IL-1β were markedly increased after MCAO.Significantly increased DNA fragmentation,the indication of apoptosis,was detected after MCAO.The expression of TNF-α and the content of IL-1β were significantly lower in AG group than those in IS group.The percentage of apoptosis cells and expression of Bax protein were markedly lower in AG group than those in IS group but still significantly higher than those in SH group.The expression of Bcl-2 protein was markedly higher in AG group than that in IS group.No significant difference in the expression of Bcl-2 protein between IS and SH group was observed.CONCLUSION: AG inhibits the increase in the expression of TNF-α and the content of IL-1β,and protects neurons from apoptosis induced by focal cerebral ischemia through increasing the Bcl-2 protein expression and inhibiting the Bax protein expression.     

Effect of peurarin pretreatment on endothelial nitric oxide synthase in rat brain tissues at the early stage of cerebral ischemia in rats

AIM: To investigate the neuroprotective effect of puerarin on the expression of endothelial nitric oxide synthase (eNOS) in rat brain tissues at the early stage of cerebral ischemia.METHODS: Forty-five rats were randomized into 3 groups: 5 in sham-operated group (S group), 20 in cerebral ischemia group (M group) and 20 in puerarin pretreatment group (P group).The rats in M group and P group were further divided into 4 subgroups to apply cerebral ischemia for 0.5 h, 1 h, 2 h and 4 h,respectively.The rats were subject to middle cerebral artery occlusion (MCAO) except those in S group.Puerarin was administered with intraperitoneal injection (100 mg/kg, ip) in P group 10 min before MCAO.The equal volume of the vehicle was administered in M groups and S group at the same time.Neurological deficit scores were determined to evaluate the functional changes of the central nervous system.The pathological changes of the brain tissues were observed under microscope with neuron nissl body staining.The protein expression and distribution of eNOS in the brain tissues were evaluated by the methods of immunohistochemistry and Western blotting.RESULTS: Neurological deficit scores of the rats in all subgroups of P groups were significantly lower than those in the corresponding subgroups of M groups (P<0.05).The dissolution extent of neuron nissl body in P groups was lower than that in M groups.The protein expression of eNOS in the brain tissues in all subgroups of P groups was higher than that in the corresponding subgroups of M groups.CONCLUSION: Pretreatment with puerarin protects brain tissues from injury of cerebral ischemia at the early stage by up-regulating the protein expression of eNOS in the brain tissues.     

Antidepressant-like effect of N-palmitoylethanolamide by prefrontal cortex PPARα pathway in a rat model

AIM: To investigate the role of cortical peroxisome proliferator-activated receptor α (PPARα) in the regulation of depression-like behavior in the rats by N-palmitoylethanolamide (PEA). METHODS: A rat model of chronic unpredictable mild stress (CUMS) was established. The rats (n=70) were randomly divided into normal control group, CUMS model group, CUMS+ fluoxetine (10 mg/kg) group, CUMS+ PEA (2.5, 5 and 10 mg/kg) groups and CUMS+ PEA (10 mg/kg)+ MK886 (3 mg/kg) group. On the 8th day during CUMS, the drugs were continuously admi-nistered for 28 d. The body weight and the related behavioral changes in the open-field test and sucrose consumption test were monitored every week. On the 36th day, some of the brain tissues from the rats were fixed in 4% formalin solution for histomorphological and immunohistochemical observations to determine the number and morphological changes of prefrontal cortex (PFC) neurons and the protein expression of synaptophysin (SYP). Other brain tissues were quickly removed, PFC was separated and weighed, and Western blot and RT-PCR were used to detect the expression of PPARα at protein and mRNA levels in the PFC of rats. RESULTS: Compared with CUMS model group, PEA increased the body weight gain, the sucrose preference rate, and the locomotion time and distance in the open-field test, and shortened the immobility time in the open-field test. PEA increased the weight of PFC, the percentage of PFC/brain weight and the number of neurons in PFC, and improved the morphological changs of the neurons. PEA also up-regulated the protein expression of SYP in PFC, and down-regulated the expression of PPARα at mRNA and protein levels in the PFC of CUMS model rats (P<0.05). In addition, compared with PEA (10 mg/kg) group, MK886 significantly reduced the body weight gain of the rats, the percentage of sucrose preference and the locomotion distance in the open-field test, and increased the immobility time in the open-field test on the 35th day during CUMS. The number of neurons SYP expression in PFC tissues were decreased, and the expression of PPARα at protein and mRNA levels was increased in MK886 group. CONCLUSION: PEA may antagonize the depression-like behavior of rats by regulating the PPARα pathway in PFC, improving synaptic plasticity of PFC and protecting the neurons.